Innovative diagnostic test could revolutionise cervical cancer screening

Coinciding with Cervical Cancer Prevention Week, researchers at St George’s are working on a field study to fine-tune an exciting new method of human papilloma virus testing that could revolutionise care for women in low and middle income countries.

The research team have partnered with molecular diagnostics firm QuantuMDx for the study, using the company’s Q-POC™ platform and its human papilloma virus (HPV) assay. The Q-POC™ compresses a molecular diagnostics laboratory into a simple-to-use, portable, affordable and battery-operated device that can be used anywhere, from basic rural settings to clinics and hospitals.

IMG 0984 edits 002